Morbidity and mortality after bilateral simultaneous total knee arthroplasty in a fast-track setting

Background and purpose — The safety aspects of bilateral simultaneous total knee arthroplasty (BSTKA) are still debated. In this retrospective single-center study, we investigated early morbidity and mortality following BSTKA in a modern fast-track setting. We also identified risk factors for re-adm...

Full description

Bibliographic Details
Main Authors: Kirill Gromov, Anders Troelsen, Kristian Stahl Otte, Thue Ørsnes, Henrik Husted
Format: Article
Language:English
Published: Taylor & Francis Group 2016-05-01
Series:Acta Orthopaedica
Online Access:http://dx.doi.org/10.3109/17453674.2016.1141631
id doaj-ecff762cd51948ca87523ffe0c4d0bc8
record_format Article
spelling doaj-ecff762cd51948ca87523ffe0c4d0bc82021-02-02T04:10:14ZengTaylor & Francis GroupActa Orthopaedica1745-36741745-36822016-05-0187328629010.3109/17453674.2016.11416311141631Morbidity and mortality after bilateral simultaneous total knee arthroplasty in a fast-track settingKirill Gromov0Anders Troelsen1Kristian Stahl Otte2Thue Ørsnes3Henrik Husted4Copenhagen University Hospital HvidovreCopenhagen University Hospital HvidovreCopenhagen University Hospital HvidovreCopenhagen University Hospital HvidovreCopenhagen University Hospital HvidovreBackground and purpose — The safety aspects of bilateral simultaneous total knee arthroplasty (BSTKA) are still debated. In this retrospective single-center study, we investigated early morbidity and mortality following BSTKA in a modern fast-track setting. We also identified risk factors for re-admission within 90 days and for a length of stay (LOS) of more than 5 days. Patients and methods — 284 patients were selected to receive BSTKA at our institution from 2008 through 2014 in a well-described, standardized fast-track setup (Husted 2012a, b). All re-admissions within 90 days were identified and mortality rates and time until death were recorded. Transfusion rates and numbers of transfusions were also recorded. Logistic regression analysis was used to identify risk factors for re-admission within 90 days, and also for a LOS of more than 5 days. Results — 90-day mortality was 0%. 10% of the patients were re-admitted within 90 days. Median time to re-admission was 18 (3–75) days. 153 patients (54%) received postoperative blood transfusions. An ASA score of 3 was identified as an independent risk factor for re-admission within 90 days (OR = 5, 95% CI: 1.3–19) and for LOS of > 5 days (OR = 6, 95% CI: 1.6–21). Higher BMI was a weak risk factor for re-admission within 90 days. Interpretation — BSTKA in selected patients without cardiopulmonary disease in a fast-track setting appears to be safe with respect to early postoperative morbidity and mortality. Surgeons should be aware that patients with an ASA score of 3 have an increased risk of re-admission and a prolonged length of stay, while patients with higher BMI have an increased risk of re-admission following BSTKA.http://dx.doi.org/10.3109/17453674.2016.1141631
collection DOAJ
language English
format Article
sources DOAJ
author Kirill Gromov
Anders Troelsen
Kristian Stahl Otte
Thue Ørsnes
Henrik Husted
spellingShingle Kirill Gromov
Anders Troelsen
Kristian Stahl Otte
Thue Ørsnes
Henrik Husted
Morbidity and mortality after bilateral simultaneous total knee arthroplasty in a fast-track setting
Acta Orthopaedica
author_facet Kirill Gromov
Anders Troelsen
Kristian Stahl Otte
Thue Ørsnes
Henrik Husted
author_sort Kirill Gromov
title Morbidity and mortality after bilateral simultaneous total knee arthroplasty in a fast-track setting
title_short Morbidity and mortality after bilateral simultaneous total knee arthroplasty in a fast-track setting
title_full Morbidity and mortality after bilateral simultaneous total knee arthroplasty in a fast-track setting
title_fullStr Morbidity and mortality after bilateral simultaneous total knee arthroplasty in a fast-track setting
title_full_unstemmed Morbidity and mortality after bilateral simultaneous total knee arthroplasty in a fast-track setting
title_sort morbidity and mortality after bilateral simultaneous total knee arthroplasty in a fast-track setting
publisher Taylor & Francis Group
series Acta Orthopaedica
issn 1745-3674
1745-3682
publishDate 2016-05-01
description Background and purpose — The safety aspects of bilateral simultaneous total knee arthroplasty (BSTKA) are still debated. In this retrospective single-center study, we investigated early morbidity and mortality following BSTKA in a modern fast-track setting. We also identified risk factors for re-admission within 90 days and for a length of stay (LOS) of more than 5 days. Patients and methods — 284 patients were selected to receive BSTKA at our institution from 2008 through 2014 in a well-described, standardized fast-track setup (Husted 2012a, b). All re-admissions within 90 days were identified and mortality rates and time until death were recorded. Transfusion rates and numbers of transfusions were also recorded. Logistic regression analysis was used to identify risk factors for re-admission within 90 days, and also for a LOS of more than 5 days. Results — 90-day mortality was 0%. 10% of the patients were re-admitted within 90 days. Median time to re-admission was 18 (3–75) days. 153 patients (54%) received postoperative blood transfusions. An ASA score of 3 was identified as an independent risk factor for re-admission within 90 days (OR = 5, 95% CI: 1.3–19) and for LOS of > 5 days (OR = 6, 95% CI: 1.6–21). Higher BMI was a weak risk factor for re-admission within 90 days. Interpretation — BSTKA in selected patients without cardiopulmonary disease in a fast-track setting appears to be safe with respect to early postoperative morbidity and mortality. Surgeons should be aware that patients with an ASA score of 3 have an increased risk of re-admission and a prolonged length of stay, while patients with higher BMI have an increased risk of re-admission following BSTKA.
url http://dx.doi.org/10.3109/17453674.2016.1141631
work_keys_str_mv AT kirillgromov morbidityandmortalityafterbilateralsimultaneoustotalkneearthroplastyinafasttracksetting
AT anderstroelsen morbidityandmortalityafterbilateralsimultaneoustotalkneearthroplastyinafasttracksetting
AT kristianstahlotte morbidityandmortalityafterbilateralsimultaneoustotalkneearthroplastyinafasttracksetting
AT thueørsnes morbidityandmortalityafterbilateralsimultaneoustotalkneearthroplastyinafasttracksetting
AT henrikhusted morbidityandmortalityafterbilateralsimultaneoustotalkneearthroplastyinafasttracksetting
_version_ 1724306390218964992